Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...

Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches ...

Nutriband Inc. (NASDAQ:NTRB) saw its stock rise 8% on Friday following news that the U.S. Food and Drug Administration (FDA) has approved a Type C Meeting for its lead product, AVERSA FENTANYL — an ...

The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from patient and pharmacy access because of a packaging flaw that has resulted in ...

FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization.

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance. Nutriband ...